Medical Devices Spain

Spain Smart Inhalers Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Spain Smart Inhalers Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Spain · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.2 Mn Placeholder estimate
Estimate 2025 $4.9 Mn 1.7% of the global market
Projected 2034 $23.3 Mn 371.4% Adds $18.3 Mn over 9 forecast years
CAGR 2025–2034 18.8% Faster than 94% of 173 Medical Devices markets here
Key players 5
  • Spain is 1.72% of the global market.
  • In Europe, the largest is Germany at $10.9 Mn.
  • Fastest growing: Russia at 20.2% a year.
  • Spain ranks 5th of 6 by size in Europe.

Market size projection

Spain

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$18.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Smart Inhalers Market market size by year, Spain
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.2 Mn — —
2025 (base) $4.9 Mn +$0.8 Mn —
2026 (forecast) $5.9 Mn +$0.9 Mn +18.8%
2027 (forecast) $7.0 Mn +$1.1 Mn +41.1%
2028 (forecast) $8.3 Mn +$1.3 Mn +67.7%
2029 (forecast) $9.8 Mn +$1.6 Mn +99.2%
2030 (forecast) $11.7 Mn +$1.8 Mn +136.6%
2031 (forecast) $13.9 Mn +$2.2 Mn +181.1%
2032 (forecast) $16.5 Mn +$2.6 Mn +234%
2033 (forecast) $19.6 Mn +$3.1 Mn +296.8%
2034 (forecast) $23.3 Mn +$3.7 Mn +371.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Spain Smart Inhalers Market Analysis at a glance
Market size, 2025$4.9 Mn placeholder estimate
Forecast, 2034$23.3 Mn placeholder estimate
Growth (CAGR), 2025–203418.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersPropeller Health, Adherium, Teva Pharmaceutical, AstraZeneca, Cohero Health (see all)
Regulator in SpainAEMPSSource: Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Spain Smart Inhalers Market Analysis Executive Summary

Smart inhalers record when and how a patient uses an inhaler and send reminders, helping control asthma and COPD.

Key segments of the smart Inhalers market include product (Inhaler Add-On Sensors and Integrated Smart Inhalers) and indication (Asthma and COPD).

Bar chart: Spain Smart Inhalers market size, 2024–2034, placeholder estimates. $4.2 Mn in 2024, $4.9 Mn in 2025 and $23.3 Mn in 2034, 18.8% CAGR.
Spain Smart Inhalers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Spain Smart Inhalers Market Dynamics

Market Growth Drivers

Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the smart Inhalers market. Doctors are starting to use wearable data in care decisions.

Opportunity

Medical-grade wearables, links to virtual care programs and insurer-funded prevention give the smart Inhalers market strong growth.

Market Restraints

Questions about accuracy, data privacy, limited reimbursement and users who stop wearing devices hold back the smart Inhalers market.

Competitive Landscape for Smart Inhalers Market in Spain

The smart Inhalers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Smart Inhalers Market in Spain

Smart Inhalers in Spain: rules and payment

Medical devices need CE marking under the EU Medical Device Regulation (MDR); AEMPS, the Spanish Agency of Medicines and Medical Devices, oversees them in Spain.⁠[1] The National Health System (SNS), run by the regions, gives universal public care.⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how smart Inhalers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Spain.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Smart Inhalers right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Smart Inhalers in context

Spain compared

  • Health spending per person: 3,107 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 4.29 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 21.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Smart Inhalers market in Spain?
Placeholder estimate: about $4.9 Mn in 2025, rising to about $23.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Smart Inhalers market in Spain growing?
Placeholder estimate: about 18.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Smart Inhalers market report cover?
The report splits the market by product (Inhaler Add-On Sensors, Integrated Smart Inhalers), indication (Asthma, COPD) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Smart Inhalers market?
Key players include Propeller Health, Adherium, Teva Pharmaceutical, AstraZeneca and Cohero Health.
What is driving the Smart Inhalers market?
Better sensors, longer battery life, smartphone apps and interest in tracking health every day are driving the smart Inhalers market. Doctors are starting to use wearable data in care decisions.
Who regulates Smart Inhalers in Spain?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); AEMPS, the Spanish Agency of Medicines and Medical Devices, oversees them in Spain. Source: Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
How is healthcare paid for in Spain?
The National Health System (SNS), run by the regions, gives universal public care. Source: Spanish Ministry of Health. Checked 14 Nov 2026.
How much research is published on Smart Inhalers?
PubMed lists 47 papers on Smart Inhalers added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Spain

See all

Related on respiratory and remote monitoring and wearables

See the topic